Program

  

 

Day 1 - Saturday, 25 May 2019

 
 9:00 AMThe opening of the workshop 
 Session 1: HIV/AIDS in China
Chairs: Yongtao Sun, Wei Lyu
 9:15 AMStudy on HIV variation and evolution and its impact on molecular epidemiology and drug resistance surveillance
Yiming Shao, MD, PhD
China CDC
 
 

9:40 AM

Guidelines for diagnosis and treatment of HIV/AIDS in China (2018)
Taisheng Li, MD, PhD
Peking Union Medical College Hospital, China
 
 10:05 AMCoffee break 
 Session 2: Prevention of HIV-infection
Chairs: Hao Wu, Yaokai Chen
 10:35 AMHIV Pre-Exposure Prophylaxis (PrEP)
Roy Gulick, MD, MPH
Weill Medical College of Cornell University, USA
 
 11:00 AMPrEP uptake preferences among men who have sex with men in
China: results from a National Internet Survey
Fujie Zhang, MD, PhD 
Beijing Ditan Hospital, Capital Medical University, China
 11:25 AMDiscussion 
 11:40 AMGroup photo 
 11:50 AMLunch 
 12:50 PM Satellite symposium
A new HIV treatment Era: F/TAF backbone
 Session 3: 
Antiviral Therapy & Cure
Chairs: Weiping Cai, Biao Zhu
 1:50 PMHIV Drug Resistance 
Charles Boucher, MD, PhD
Erasmus Medical Center, Erasmus University, the Netherlands
 
 2:15 PMNovel treatment strategies - two versus three drugs
Jonathan Schapiro, MD
Sheba Medical Center, Israel
 
 2:40 PMProgress review on HIV Cure
Bonaventura Clotet, MD, PhD
Hospital Universitari " Germans Trias I Pujol", Spain
 
 3:05 PMDiscussion 
 3:20 PMCoffee break / Poster viewing 
 Session 4: 
Clinical management of HIV coinfections
Chairs: Yun He, Hongxia Wei
 3:50 PMHIV/TB co-infection in China
Hongzhou Lu, MD, PhD
Shanghai Public Health Clinical Center, Fudan University, China
 
 4:15 PMClinical characteristics and prognostic factors of cryptococcal meningitis among HIV-infected  patients
Yinzhong Shen, MD
Shanghai Public Health Clinical Center, Fudan University, China
 
 4:40 PM

Clinical management of HIV-HBV and HIV-HCV coinfection 
Jürgen Rockstroh, MD, PhD

University of Bonn, Germany

 
 5:05 PMDiscussion 
 5:20 PMEnd of Day 1 
 

Day 2 - Sunday, 26 May 2019

 
 Session 5: 
Progress in HBV treatment
Chairs: Hui Zhuang, Hui Wang
 9:00 AMProgress on HBV treatment
Jinlin Hou, MD 
Nanfang Hospital, Southern Medical University, China
 
 9:25 AM

HBV-infection in immune comprised people
Wenhong Zhang, MD, PhD 
Huashan Hospital, Fudan University, China

 
 

9:50 AM

 

Novel biomarkers for chronic hepatitis B
Xiaonan Zhang, PhD
Shanghai Public Health Clinical Center, China
 
 10:15 AMDiscussion 
 10:30 AMCoffee break 
 11:00 AM

Update of Chronic hepatitis B with fatty liver
Jiangao Fan, MD, PhD
Xinhua Hospital Affiliated to Shanghai Jiaotong University, China

 
 11:25 AM

Acute on chronic liver failure ( TBC)
Yumin Xu, MD, PhD
Ruijin Hospital Affiliated to Shanghai Jiaotong University, China

 
 11:50 AMDiscussion 
 12:00 AMLunch 
 1:00 PM 
Satellite Symposium:
Adaptable Best Practice Service Models for HIV & Viral Hepatitis
  Scott McGill
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine
Australia
 
  Special talk supported by Becton Dickinson 
  2:00 PMThe advanced technology of MDR-TB diagnosis
Xin Shen
Shanghai CDC, China
 
 Session 6: 
Progress in HCV Treatment
Chair: Lingyun Shao
 2:25 PMHCV epidemiology
Lai Wei, MD
Peking University People's Hospital, China
 
 2:50 PMHepatitis C therapy: Unique issues and Challenges in Asia
Pei-Jer Chen, MD, PhD
Nation Taiwan University College of Medicine Institute of Molecular Medicine
 3:15 PMThe superinfection of hepatitis E virus in chronic hepatitis patients
Jun Zhang, PhD
School of Public Health, Xiamen University,China
 
 3:40 AMDiscussion 
 3:50 AMCoffee break 
 Session 7: 
Progress in viral hepatitis Cure/Elimination
Chair: Liang Chen
 4:20 PM Progress HBV cure research
Jidong Jia, MD, PhD
Beijing Friendship Hospital, Capital Medical University, China
 
 4:45 PMProgress HCV cure / HCV elimination
Jürgen Rockstroh, MD, PhD
University of Bonn, Germany
 
 5:10 PMDiscussion 
 5:20 PMClosing remark
Wenhong Zhang, MD, PhD
Xinhua Hospital Affiliated to Shanghai Jiaotong University, China
 
 5:35 PMEnd of Day 2 

 *Simultaneous interpretation will be offered throughout the meeting.